← All companies

BEAM

Beam Therapeutics Inc.

BEAM Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$25.91

-0.58 -2.19%

Key statistics

from XBRL data in SEC filings

Market cap

$2.67B

Revenue (TTM)

$164M

Net income (TTM)

-$66.0M

EPS (TTM)

$-0.49

P/E ratio

—

Dividend yield

—

Free cash flow

-$360M

Cash

$288M

Total assets

$1.48B

Gross margin

—

52-week range

$15.60 – $38.26

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 8, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Terminated a material agreement Mar 5, 2026 10-K Fiscal year ended 2025-12-31 Feb 24, 2026 8-K Entered a material agreement; Results of operations (earnings release); Took on a direct financial obligation Feb 24, 2026 8-K Entered a material agreement Feb 12, 2026 8-K Director or officer change Feb 5, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 8-K Completed an acquisition or disposition Dec 11, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release) Nov 4, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Unregistered sale of equity Jul 3, 2025 8-K Shareholder vote results Jun 6, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 8-K Entered a material agreement; Other events Mar 10, 2025 8-K Regulation FD disclosure; Other events Mar 10, 2025 10-K Fiscal year ended 2024-12-31 Feb 25, 2025 8-K Results of operations (earnings release) Feb 25, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 13, 2025 8-K Regulation FD disclosure; Other events Dec 9, 2024 8-K Director or officer change; Regulation FD disclosure Dec 6, 2024 8-K Director or officer change; Regulation FD disclosure Dec 4, 2024 10-Q Quarter ended 2024-09-30 Nov 5, 2024 8-K Other events Nov 5, 2024 8-K Regulation FD disclosure Nov 5, 2024 8-K Results of operations (earnings release) Nov 5, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Director or officer change Jul 15, 2024 8-K Shareholder vote results Jun 10, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 10-K Fiscal year ended 2023-12-31 Feb 27, 2024 8-K Results of operations (earnings release) Feb 27, 2024 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 8, 2024 8-K Director or officer change Dec 14, 2023